Carvalho, Jonatan C. S. de; Silva Neto, Pedro Vieira da 
; Toro, Diana Mota; Fuzo, Carlos Alessandro ; Nardini, Viviani ; Pimentel, Vinícius Eduardo ; Pérez, Malena Martínez ; Fraga-Silva, Thais Fernanda de Campos ; Oliveira, Camilla N. S.; Degiovani, Augusto Marcussi; Ostini, Fátima Magro; Feitosa, Marley Ribeiro ; Parra, Rogério Serafim ; Rocha, José Joaquim Ribeiro da ; Féres, Omar ; Vilar, Fernando Crivelenti ; Gaspar, Gilberto Gambero ; Santos, Isabel Kinney Ferreira de Miranda ; Fernandes, Ana Paula Morais ; Maruyama, Sandra Regina Costa ; Russo, Elisa Maria de Sousa ; Bonato, Vânia Luiza Deperon ; Cardoso, Cristina Ribeiro de Barros ; Dias-Baruffi, Marcelo ; Faccioli, Lucia Helena ; Sorgi, Carlos Arterio
Source: Viruses. Unidades: FMRP, EERP, FCFRP, FFCLRP, FM
Subjects: COVID-19, HORMÔNIOS GLICOCORTICOIDES, FATOR DE ATIVAÇÃO DE PLAQUETAS, INFLAMAÇÃO
ABNT
CARVALHO, Jonatan C. S. de et al. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, v. 15, 2023Tradução . . Disponível em: https://doi.org/10.3390/v15020573. Acesso em: 27 nov. 2025.APA
Carvalho, J. C. S. de, Silva Neto, P. V. da, Toro, D. M., Fuzo, C. A., Nardini, V., Pimentel, V. E., et al. (2023). The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19. Viruses, 15. doi:10.3390/v15020573NLM
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/v15020573Vancouver
Carvalho JCS de, Silva Neto PV da, Toro DM, Fuzo CA, Nardini V, Pimentel VE, Pérez MM, Fraga-Silva TF de C, Oliveira CNS, Degiovani AM, Ostini FM, Feitosa MR, Parra RS, Rocha JJR da, Féres O, Vilar FC, Gaspar GG, Santos IKF de M, Fernandes APM, Maruyama SRC, Russo EM de S, Bonato VLD, Cardoso CR de B, Dias-Baruffi M, Faccioli LH, Sorgi CA. The interplay among glucocorticoid therapy, platelet-activating factor and endocannabinoid release influences the inflammatory response to COVID-19 [Internet]. Viruses. 2023 ; 15[citado 2025 nov. 27 ] Available from: https://doi.org/10.3390/v15020573
